scispace - formally typeset
Y

Yongchao Zhao

Researcher at Zhejiang University

Publications -  66
Citations -  8521

Yongchao Zhao is an academic researcher from Zhejiang University. The author has contributed to research in topics: Ubiquitin ligase & DEPTOR. The author has an hindex of 22, co-authored 56 publications receiving 6753 citations. Previous affiliations of Yongchao Zhao include University of Michigan & Tsinghua University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and Autophagy

TL;DR: It is reported that DEPTOR is a physiological substrate of SCF(βTrCP) E3 ligase for targeted degradation by SCF E3 for ubiquitin-proteasome pathway degradation.
Journal ArticleDOI

Cullin-RING Ligases as Attractive Anti-cancer Targets

TL;DR: The UPS and CRL E3s are introduced and the biological processes regulated by each of eight CRLs through substrate degradation are discussed, including how cullin neddylation controls CRL activity, and how CRL's are being validated as the attractive cancer targets by abrogating the RING component through genetic means and by inhibiting cullinNEDylation via MLN4924, a small molecule indirect inhibitor of CRLS, currently in several Phase I clinical trials.
Journal ArticleDOI

Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy

TL;DR: MLN4924, a small molecule inhibitor of NAE, was discovered that inactivates CRLs and causes accumulation of CRL substrates to suppress tumor cell growth both in vitro and in vivo.